United States · FDA National Drug Code directory
ILUMYA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-177_edc3f29f-1b74-4e56-ad3e-b6f213ce56d2
- Product NDC
- 47335-177
- Form
- INJECTION, SOLUTION
- Composition / generic term
- tildrakizumab-asmn
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20180806
- Source listing expiry
- 20271231
Source-listed ingredients
- TILDRAKIZUMAB — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 mL in 1 SYRINGE, GLASS (47335-177-01) · 47335-177-01
- 1 mL in 1 CARTON (47335-177-10) · 47335-177-10
- 1 mL in 1 CARTON (47335-177-95) · 47335-177-95
- 1 mL in 1 SYRINGE, GLASS (47335-177-96) · 47335-177-96
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →